Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia-Reference-Cited by-同舟云学术

Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia

Published:2024-03-11 Issue:1 Volume:27 Page:418-429
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Al-Omar Hussain A.¹²^ORCID,Almodaimegh Hind S.³⁴⁵^ORCID,Omaer Abubker⁶^ORCID,Alzubaidi Lamya M.⁷^ORCID,Al-Harbi Bandar⁸,Al-Harbi Ibtisam⁹,Hassan Mohamed¹⁰,Akhtar Omar¹¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2. Health Technology Assessment Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

3. College of Pharmacy, King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia

4. Pharmaceutical Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

5. King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

6. Department of Clinical Pharmacy, King Saud Medical City, Riyadh, Saudi Arabia

7. Therapeutic Deputyship, Ministry of Health, Riyadh, Saudi Arabia

8. Department of Pharmacy, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

9. Department of Pharmacy, Jeddah Military Hospital, Jeddah, Saudi Arabia

10. Novo Nordisk, Riyadh, Saudi Arabia

11. Poa Alpina Research, Seoul, South Korea

Funder

Novo Nordisk Saudi Arabia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2319458

Reference63 articles.

1. Type 2 diabetes

2. The WHO Global Diabetes Compact: a new initiative to support people living with diabetes

3. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses

4. Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries

5. Prevalence of type 2 diabetes mellitus and related factors among the general adult population in Saudi Arabia between 2016–2022: A systematic review and meta-analysis of the cross-sectional studies